Fundraising FoxRareCan
3 known investors
Find your way into RareCan
Sign up to see every warm intro you have to RareCan
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RareCan team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RareCan provides cancer treatment and clinical trial access tailored to individual patients, with a focus on improving outcomes for people diagnosed with rare cancers.
Founders & leadership
PK
Piers KottingChief Executive OfficerPiers Kotting held clinical and managerial roles in NHS acute and mental health services before spending 15 years in research and development with the National Institute for Health and Care Research; he has founded multiple health tech companies and holds an MBA. As CEO of RareCan, he leads a platform connecting cancer patients with clinical trial and treatment opportunities tailored to rare cancer diagnoses.
SA
Simon AlloccaChief Financial OfficerHe brings corporate and investment banking experience, expertise in risk and governance, and background in business leadership and financial restructuring across multiple organizations.
Investors · 3
Also in the syndicate · 1
Women Angels of the North Syndicate
Funding
SEC filings, press & company announcements- Undisclosed amountseed funding roundJun 2022
Women Angels of the North Syndicate
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does RareCan do?
- RareCan provides cancer treatment and clinical trial access tailored to individual patients, with a focus on improving outcomes for people diagnosed with rare cancers.
- Who are RareCan's investors?
- RareCan's investors include Anglia Capital Group, Cambridge Angels group.